The DCB is meant to address long-term stent-related complications and avoid adding yet another metal layer in ISR.

The data are largely in line with those seen at 5 years, but the follow-up reassures there’s no concern about valve ...

Reaching participants through retail pharmacies, the study speaks to how much VHD goes underrecognized—with a few surprises.

Bioadaptor was designed to restore normal vessel function and reduce late stent-related complications. It’s working so far.

The device, which is delivered transapically, represents an option for very sick patients who previously have had none.

Having more-thorough workup uncovered an unexpected root cause and changed the treatment course for 76% of patients.

The real-world Evoque and new TRILUMINATE findings provide an “extension” from the pivotal trials, Dharam Kumbhani says.

Researchers hoped the technique might involve lower exposure compared with right transradial access, but this didn’t pan out.

The rate of death or HF hospitalization was not influenced by the presence of leads after accounting for comorbidity burden.

The intracoronary fibrinolysis infusion joins a host of other failed treatments to improve microvascular obstruction after ...

Modern is consistent with the literature in this space, but the trial shows that a staged complete procedure might be just ...

“Cutting balloon angioplasty is a reasonable and less costly option when compared with intravascular lithotripsy for the ...